Parkinsonism & related disorders
Comparative pharmacokinetics of levodopa-carbidopa intestinal gel infusion and foslevodopa-foscarbidopa continuous subcutaneous infusion therapies in advanced Parkinson's disease.
Yohei Mukai, Junko Takei, Juri Nomoto, Motohiro Okumura, Shinji Oda, Tasuku Ishihara, Yuka Hama, Hotake Takizawa, Toru Yamakawa, Fumiko Furukawa, Jun Shinmi, Shoya Inagawa, Shuho Namatame, Yuji Takahashi
Published: 202610.1016/j.parkreldis.2026.108197
Abstract
INTRODUCTION: Levodopa-carbidopa intestinal gel therapy (LCIG) and foslevodopa-foscarbidopa continuous subcutaneous infusion therapy (FOCS) are device-aided therapies for advanced Parkinson's disease. Comparative real-world pharmacokinetic (PK) data…
Preview only. Read the full abstract at the source